Your browser doesn't support javascript.
loading
Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
Cheng, Chieh-Lung; Yao, Chi-Yuan; Huang, Po-Hao; Yu, Chih-Wei; Fang, Wei-Quan; Chuang, Wen-Hui; Wu, Shang-Ju; Lin, Yu-Jen; Hung, Yu-Chin; Tsai, Cheng-Hong; Yu, Shan-Chi; Chou, Wen-Chien; Tien, Hwei-Fang.
Afiliación
  • Cheng CL; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Yao CY; Department of Laboratory Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Huang PH; Division of Neurosurgery, Department of Surgery, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Yu CW; Department of Radiology and Medical Imaging, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Fang WQ; Division of New Drug, Center for Drug Evaluation, Taipei, Taiwan.
  • Chuang WH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Wu SJ; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Lin YJ; Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Hung YC; Division of Hematology and Oncology, Department of Internal Medicine, National Taiwan University Hospital, Yunlin, Taiwan.
  • Tsai CH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Yu SC; Department of Pathology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Chou WC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Tien HF; Department of Laboratory Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Br J Haematol ; 201(1): 75-85, 2023 04.
Article en En | MEDLINE | ID: mdl-36480431

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Linfoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Linfoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán